SCHEMBL18969703

SCHEMBL18969703

Cc1ccc(-n2c(C)c(C)c3ccccc32)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.47
▸ L3MBTL1 Q9Y468 3/20 0.47
▸ ATM Q13315 1/20 0.47
▸ MAPT P10636 4/20 0.43
▸ HTT P42858 2/20 0.43
▸ LMNA P02545 1/20 0.43
▸ POLB P06746 1/20 0.42
▸ METAP2 P50579 1/20 0.41
▸ HDAC6 Q9UBN7 2/20 0.40
▸ RORC P51449 1/20 0.40
▸ GAA P10253 2/20 0.40
▸ PLA2G2A P14555 1/20 0.40
▸ ALOX15 P16050 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ SMN1; SMN2 Q16637 4/20 0.40
▸ ALDH1A1 P00352 4/20 0.39
▸ USP14 P54578 1/20 0.38
▸ NPC1 O15118 2/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ MEN1 O00255 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17906205 0.90 KDM4E (0.59) KDM4EL3MBTL1ATMMAPTHTT
SCHEMBL11379057 0.88 KDM4E (0.61) KDM4EL3MBTL1ATMMAPTHTT
SCHEMBL2758580 0.85 KDM4E (0.44) KDM4EL3MBTL1ATMMAPTHTT
SCHEMBL17906201 0.85 KDM4E (0.44) KDM4EL3MBTL1ATMMAPTHTT
SCHEMBL31373768 0.84 KDM4E (0.67) KDM4EL3MBTL1ATMMAPTHTT
SCHEMBL29110 0.84 KDM4E (0.67) KDM4EL3MBTL1ATMMAPTHTT
SCHEMBL5608517 0.83 KDM4E (0.41) KDM4EL3MBTL1ATMMAPTHTT
SCHEMBL22454015 0.82 KDM4E (0.41) KDM4EL3MBTL1ATMHTTLMNA
SCHEMBL7140707 0.82 MAPT (0.54) KDM4EL3MBTL1ATMMAPTHTT
SCHEMBL18381849 0.82 KDM4E (0.64) KDM4EL3MBTL1ATMMAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10297755-B2 Oxygen substituted benzoclobutenes derived compositions for electronic devices DOW GLOBAL TECHNOLOGIES LLC (US) 2019-05-21 — — US disclosed
US-9966537-B2 Compositions with 2,3-disubstituted indoles as charge transport materials, and display devices fabricated therefrom DOW GLOBAL TECHNOLOGIES LLC (US) 2018-05-08 — — US disclosed
US-9966537-B2 Compositions with 2,3-disubstituted indoles as charge transport materials, and display devices fabricated therefrom DOW GLOBAL TECHNOLOGIES LLC (US) 2018-05-08 — — US disclosed
US-20170373253-A1 Compositions with 2,3-Disubstituted Indoles as Charge Transport Materials, and Display Devices Fabricated Therefrom DOW GLOBAL TECHNOLOGIES LLC 2017-12-28 — — US disclosed
US-20170170398-A1 OXYGEN SUBSTITUTED BENZOCLOBUTENES DERIVED COMPOSITIONS FOR ELECTRONIC DEVICES DOW GLOBAL TECHNOLOGIES LLC (US) 2017-06-15 — — US disclosed
US-20170170398-A1 OXYGEN SUBSTITUTED BENZOCLOBUTENES DERIVED COMPOSITIONS FOR ELECTRONIC DEVICES DOW GLOBAL TECHNOLOGIES LLC (US) 2017-06-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170373253-A1 Compositions with 2,3-Disubstituted Indoles as Charge Transport Materials, and Display Devices Fabricated Therefrom IDO2, HTR3D, IDO1 KDM4E 3319/4885L3MBTL1 3776/4885ATM 4371/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback